Ronac Mamtani, M.D., M.S.C.E.

Assistant Professor
Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania, United States

Astellas (Consultant/Advisory Board)Bristol Myers Squibb (Consultant/Advisory Board)Flatiron Health (Consultant/Advisory Board)Merck (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Seagan (Consultant/Advisory Board)

Presentation(s):

• Association Between Very High PD-L1 Expression versus High PD-L1 Expression in Patients Receiving Pembrolizumab as First-line Treatment for Advanced Non-small Cell Lung Cancer

  Sunday, August 28, 2022
  9:30 AM – 9:45 AM CEST